Cholera Workup: Approach Considerations, Stool Examination, Stool Culture
- ️Invalid Date
Workup
Approach Considerations
Definitive diagnosis is not a prerequisite for the treatment of patients with cholera. The priority in management of any watery diarrhea is replacing the lost fluid and electrolytes and providing an antimicrobial agent when indicated.
According to World Health Organization (WHO) standard case definition, a case of cholera is suspected when the following conditions are met:
-
In an area where the disease is not known to be present, a patient aged 5 years or older develops severe dehydration or dies from acute watery diarrhea
-
In an area with a noted cholera epidemic, a patient aged 5 years or older develops acute watery diarrhea, with or without vomiting
In endemic areas, biochemical confirmation and characterization of the isolate are usually unnecessary. However, these tasks may be worthwhile in areas where Vibrio cholerae is an uncommon isolate. If identification of the organism is required, direct microscopic examination of stool (including dark-field examination) is indicated, along with Gram stain, culture, and serotype and biotype identification.
Polymerase chain reaction (PCR) tests for identifying V cholerae have been developed. These have a high degree of sensitivity and specificity. At present, however, such tests are used for screening of food samples.
Stool Examination
Vibrio cholerae is a gram-negative curved bacillus that is motile by means of a single flagellum. Laboratory diagnosis is required not only for identification but also for epidemiological purposes (see the image below).
Electron microscopic image of Vibrio cholera.
Although observed as a gram-negative organism, the characteristic motility of Vibrio species cannot be identified on a Gram stain, but it is easily seen on direct dark-field examination of the stool.
Stool Culture
V cholerae is not fastidious in nutritional requirements for growth. However, it does need an adequate buffering system if fermentable carbohydrate is present because viability is severely compromised if the pH is less than 6, often resulting in autosterilization of the culture. Many of the selective media used to differentiate enteric pathogens do not support the growth of V cholerae.
Routine differential media
Colonies are lactose-negative, like all other intestinal pathogens, but sucrose-positive. When plated onto triple-sugar iron agar to screen for Salmonella and Shigella species, the organism gives the nonpathogenic pattern of an acid (yellow) slant and acid butt because of fermentation of the sucrose contained in triple-sugar iron agar.
Unlike other Enterobacteriaceae, V cholerae is oxidase-positive; hence, in countries where selective media are not available and cholera is not endemic, V cholerae should be suspected if any motile, oxidase-positive, gram-negative rod isolated on routine differential media from the stool of a patient with diarrhea produces an acid reaction on triple sugar iron agar.
Alkaline enrichment media
As Vibrio has the ability to grow at a high pH or in bile salts, which inhibit many other Enterobacteriaceae, peptone water (pH 8.5-9) or selective media containing bile salts (eg, thiosulfate-citrate-bile-sucrose-agar [pH 8.6]) are recommended to facilitate isolation and lab diagnosis. On thiosulfate-citrate-bile-sucrose-agar, the sucrose-fermenting V cholera grow as large, smooth, round yellow colonies that stand out against the blue-green agar.
Serotyping and Biotyping
Specific antisera can be used in immobilization tests. A positive immobilization test result (ie, cessation of motility of the organism) is produced only if the antiserum is specific for the Vibrio type present; the second antiserum serves as a negative control. Vibrio antisera may be unavailable in countries where cholera is not endemic. In endemic regions, this is an excellent quick method of identification, even in small laboratories.
Classic and El Tor biotypes also can be identified using the same method. This is useful for epidemiologic studies.
Hematologic Tests
The major hematologic derangements in patients with cholera derive from the alterations in intravascular volume and electrolyte concentrations.
Hematocrit, serum-specific gravity, and serum protein are elevated in dehydrated patients because of resulting hemoconcentration. When patients are first observed, they generally have a leukocytosis without a left shift.
Metabolic Panel
Serum sodium is usually 130-135 mmol/L, reflecting the substantial loss of sodium in the stool.
Serum potassium usually is normal in the acute phase of the illness, reflecting the exchange of intracellular potassium for extracellular hydrogen ion in an effort to correct the acidosis.
Hyperglycemia may be present, secondary to systemic release of epinephrine, glucagon, and cortisol due to hypovolemia.
Patients have elevated blood urea nitrogen and creatinine levels consistent with prerenal azotemia. The extent of elevation depends on the degree and duration of dehydration.
A reduced bicarbonate level (< 15 mmol/L) and an elevated anion gap occur as a result of increases in serum lactate, protein, and phosphate levels. The arterial pH is usually low (approximately 7.2). Calcium and magnesium levels are usually high as a result of hemoconcentration.
Centers for Disease Control and Prevention. Cholera. CDC. Available at https://www.cdc.gov/cholera/about/index.html. 2024 May 12; Accessed: September 20, 2024.
Centers for Disease Control and Prevention. 150th anniversary of John Snow and the pump handle. CDC. Available at https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5334a1.htm. 2004 Sep 02; Accessed: September 20, 2024.
Kanungo S, Azman AS, Ramamurthy T, Deen J, Dutta S. Cholera. Lancet. 2022 Apr 9. 399 (10333):1429-40. [QxMD MEDLINE Link].
Todar K. Vibrio cholerae and Asiatic Cholera. Todar's Online Textbook of Bacteriology. Available at https://textbookofbacteriology.net/cholera.html. 2020; Accessed: September 20, 2024.
Pindyck T, Gutelius B, Mintz E. Cholera. Centers for Disease Control and Prevention. In: CDC Yellow Book 2024: Health Information for International Travel. New York, NY: Oxford University Press; 2023. [Full Text].
Tobin-D'Angelo M, Smith AR, Bulens SN, et al. Severe diarrhea caused by cholera toxin-producing vibrio cholerae serogroup O75 infections acquired in the southeastern United States. Clin Infect Dis. 2008 Oct 15. 47(8):1035-40. [QxMD MEDLINE Link].
CDC. Two cases of toxigenic Vibrio cholerae O1 infection after Hurricanes Katrina and Rita--Louisiana, October 2005. MMWR Morb Mortal Wkly Rep. 2006 Jan 20. 55(2):31-2. [QxMD MEDLINE Link].
WHO. Cholera: key facts. World Health Organization. Available at https://www.who.int/news-room/fact-sheets/detail/cholera. 2024 Sep 04; Accessed: September 20, 2024.
Lantagne D, Balakrish Nair G, Lanata CF, Cravioto A. The cholera outbreak in Haiti: where and how did it begin?. Curr Top Microbiol Immunol. 2014. 379:145-64. [QxMD MEDLINE Link].
Barzilay EJ, Schaad N, Magloire R, et al. Cholera surveillance during the Haiti epidemic--the first 2 years. N Engl J Med. 2013 Feb 14. 368(7):599-609. [QxMD MEDLINE Link].
Chin CS, Sorenson J, Harris JB, et al. The origin of the Haitian cholera outbreak strain. N Engl J Med. 2011 Jan 6. 364(1):33-42. [QxMD MEDLINE Link]. [Full Text].
Rehydration Project. Oral Rehydration Solutions: Made at Home. Available at https://rehydrate.org/solutions/homemade-ors.pdf. Accessed: September 23, 2024.
Global Task Force on Cholera Control. Cholera Outbreak Response. Section 7: Case Management in Treatment Facilities. Available at https://www.choleraoutbreak.org/book-page/section-7-case-management-treatment-facilities.html. 2024; Accessed: September 23, 2024.
WHO. Cholera vaccines: WHO position paper. Wkly Epidemiol Rec. 2010 Mar 26. 85(13):117-28. [QxMD MEDLINE Link].
Chen WH, Greenberg RN, Pasetti MF, et al. Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR prepared from new master and working cell banks. Clin Vaccine Immunol. 2013 Oct 30. [QxMD MEDLINE Link].
Chen WH, Cohen MB, Kirkpatrick BD, Brady RC, Galloway D, Gurwith M, et al. Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection With Vibrio cholerae O1 El Tor. Clin Infect Dis. 2016 Jun 1. 62(11):1271-81. [QxMD MEDLINE Link].
Wong KK, Burdette E, Mahon BE, Mintz ED, Ryan ET, Reingold AL. Recommendations of the Advisory Committee on Immunization Practices for Use of Cholera Vaccine. MMWR Morb Mortal Wkly Rep. 2017 May 12. 66 (18):482-485. [QxMD MEDLINE Link].
Saif-Ur-Rahman KM, Mamun R, Hasan M, Meiring JE, Khan MA. Oral killed cholera vaccines for preventing cholera. Cochrane Database Syst Rev. 2024 Jan 10. 1 (1):CD014573. [QxMD MEDLINE Link]. [Full Text].
Qadri F, Ali M, Lynch J, Chowdhury F, Khan AI, Wierzba TF, et al. Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial. Lancet Infect Dis. 2018 Jun. 18 (6):666-674. [QxMD MEDLINE Link].
Azman AS, Luquero FJ, Ciglenecki I, Grais RF, Sack DA, Lessler J. The Impact of a One-Dose versus Two-Dose Oral Cholera Vaccine Regimen in Outbreak Settings: A Modeling Study. PLoS Med. 2015 Aug. 12 (8):e1001867. [QxMD MEDLINE Link].
Qadri F, Ali M, Chowdhury F, et al. Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial. Lancet. 2015 Oct 3. 386 (10001):1362-71. [QxMD MEDLINE Link].
Matias WR, Falkard B, Charles RC, Mayo-Smith LM, Teng JE, Xu P, et al. Antibody Secreting Cell Responses following Vaccination with Bivalent Oral Cholera Vaccine among Haitian Adults. PLoS Negl Trop Dis. 2016 Jun. 10 (6):e0004753. [QxMD MEDLINE Link].
-
Electron microscopic image of Vibrio cholera.
-
Scanning electron microscope image of Vibrio cholerae bacteria, which infect the digestive system.
-
This scanning electron micrograph (SEM) depicts a number of Vibrio cholerae bacteria of the serogroup 01; magnified 22371x. Image courtesy of CDC/Janice Haney Carr.
-
This patient with cholera is drinking oral rehydration solution (ORS) in order to counteract the cholera-induced dehydration. Image courtesy of the CDC.
Author
Sajeev Handa, MBBCh, BAO, LRCSI, LRCPI Chief, Hospital Medicine, Lifespan Physician Group, Rhode Island/Miriam and Newport Hospitals
Sajeev Handa, MBBCh, BAO, LRCSI, LRCPI is a member of the following medical societies: Society of Hospital Medicine
Disclosure: Nothing to disclose.
Coauthor(s)
John W King, MD Professor of Medicine, Chief, Section of Infectious Diseases, Director, Viral Therapeutics Clinics for Hepatitis, Louisiana State University School of Medicine in Shreveport; Consultant in Infectious Diseases, Overton Brooks Veterans Affairs Medical Center
John W King, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians, American Federation for Medical Research, American Society for Microbiology, Association of Subspecialty Professors, Infectious Diseases Society of America, Sigma Xi, The Scientific Research Honor Society
Disclosure: Nothing to disclose.
Specialty Editor Board
Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference
Disclosure: Nothing to disclose.
Mark R Schleiss, MD Minnesota American Legion and Auxiliary Heart Research Foundation Chair of Pediatrics, Professor of Pediatrics, Division Director, Division of Infectious Diseases and Immunology, Department of Pediatrics, University of Minnesota Medical School
Mark R Schleiss, MD is a member of the following medical societies: American Pediatric Society, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, Society for Pediatric Research
Disclosure: Nothing to disclose.
Chief Editor
Russell W Steele, MD Clinical Professor, Tulane University School of Medicine; Staff Physician, Ochsner Clinic Foundation
Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, Southern Medical Association
Disclosure: Nothing to disclose.
Additional Contributors
Itzhak Brook, MD, MSc Professor, Department of Pediatrics, Georgetown University School of Medicine
Itzhak Brook, MD, MSc is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians-American Society of Internal Medicine, American Medical Association, American Society for Microbiology, The Society of Federal Health Professionals (AMSUS), Infectious Diseases Society of America, International Immunocompromised Host Society, International Society for Infectious Diseases, Medical Society of the District of Columbia, New York Academy of Sciences, Pediatric Infectious Diseases Society, Society for Experimental Biology and Medicine, Society for Pediatric Research, Southern Medical Association, Society for Ear, Nose and Throat Advances in Children, American Federation for Clinical Research, Surgical Infection Society, Armed Forces Infectious Diseases Society
Disclosure: Nothing to disclose.
Vidhu V Thaker, MBBCh, MD Attending Pediatrician, Haverstraw Pediatrics; Clinical Assistant Professor of Pediatrics, New York Medical College
Vidhu V Thaker, MBBCh, MD is a member of the following medical societies: American Academy of Pediatrics
Disclosure: Nothing to disclose.